Roche join Pfizer and others in price freeze while critics pose questions
July 23, 2018Sales and Marketing Donald Trump, Roche, generics, price freezes
Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …
FDA approves Pfizer biosimilar version of Amgen’s Neupogen
July 23, 2018Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma
The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …
Chinese premier slams drug maker after vaccine scandal
July 23, 2018Sales and Marketing CCP, China, biotech, scandal, vaccines
Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …
Top Ten most popular articles on Pharmafile.com this week
July 20, 2018Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10
As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …
Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics
July 20, 2018Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn
The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …
FDA explores import strategy in effort to reduce price of drugs
July 20, 2018Medical Communications Drug pricing, Trump, borders, import, the donald
The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …
Merck joins Pizer and Novartis in reducing drug prices
July 20, 2018Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes
Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …
Donald Trump thanks Novartis for halting price hikes
July 20, 2018Medical Communications Novartis, Pfizer, Trump, Twitter, price hikes
Donald Trump has thanked Swiss multinational Novartis for halting price hikes on prescription drugs in the United States. The US …
Novartis buys eczema drug in €95m deal
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent
Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …
PhRMA take on PBM’s in response to Trump drug price plan
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …
MPs vote to stay in EMA after Brexit
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote
British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …
Bill Gates commits $30m towards Alzheimer’s diagnostic test
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis
Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
Janssen’s Symtuza scores approval with the FDA in HIV-1
July 18, 2018Sales and Marketing HIV, Janssen, Symtuza, pharma
Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …
AstraZeneca increases drug stockpile in preparation for no-deal Brexit
July 18, 2018Research and Development AstraZeneca, brexit, no-deal, pharma, stockpiling
The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the …
Novartis follows Pfizer’s lead, pledges no price hikes in 2018
July 18, 2018Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma
Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …
Researchers develop algorithm able to identify antidepressant suitability
July 18, 2018Research and Development McLean, algorithm, antidepressants, research
A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …
AbbVie and Mylan reach US marketing agreement for Humira biosimilar
July 18, 2018Research and Development, Sales and Marketing AbbVie, Humira, Mylan, US, pharma
AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of …
Renowned cancer researcher leaves ICR over bullying allegations
July 17, 2018Research and Development
Leading geneticist and cancer researcher, Nazneen Rahman CBE, has resigned from her position as head of Genetics and Epidemiology at …
Silence Therapeutics appoints ex-Akari CEO in top position
July 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand
Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
Researchers successfully minimise diabetes drug side-effects in animal models
July 17, 2018Manufacturing and Production, Research and Development FDA, diabetes, pharma, type 2 diabetes
Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
